Molecular Therapies for Cardiac Arrhythmias

Leader: Gerard Boink

Expertise

Cardiac arrhythmias are a major cause of morbidity and mortality. Currently available treatment modalities range from drugs and devices to more invasive therapies such as ablation and surgery. Despite ongoing improvements in these therapies, important limitations remain. To change this unfortunate state of affairs I have dedicated my research to the development of molecular therapies for cardiac arrhythmias. These efforts currently focus on the following therapeutic interventions:

  • Gene and cell therapy-based biological pacing
  • Direct reprogramming for myocardial regeneration and repair of the pacemaker and conduction system
  • Gene and cell therapy to prevent myocardial infarction-related arrhythmias

Team members

namefunction
Gerard BoinkGroup Leader
Dirk GeertsScientist
Harsha DevallaScientist
Max Medina RamirezScientist
Rajiv MohanScientist
Alexandra WiesingerPhD student
Jianan WangPhD student
Jiuru LiPhD student
Mischa KlerkTechnician
Veronique Roolker- KnaupTechnician
Anat BouwmeesterStagiaire HBO
Lotte GeerlingsStagiaire HBO
Maikel van de VenStagiaire HBO

Key publications